Abeona Therapeutics Inc vs FTAI Aviation Ltd — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while FTAI Aviation Ltd trades at $225.49 (market cap $23.17B). The key difference: FTAI Aviation Ltd is far larger — about 55× Abeona Therapeutics Inc's market cap, and FTAI Aviation Ltd pays a 0.89% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | FTAI | |
|---|---|---|
Market Cap | $421.19M | $23.17B |
Sector | Health | Industrials |
52-Week High | $7.45 | $310.04 |
52-Week Low | $4.17 | $140.40 |
Enterprise Value | $276.10M | $26.29B |
Dividend Yield | — | 0.89% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →